LANTUS (insulin glargine recombinant) – a acting human insulin analog indicated to improve glycemic control in adults and children with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. The primary activity of insulin, including insulin glargine, is regulation of glucose metabolism. Insulin and its analogs lower blood glucose by stimulating peripheral […]
JANUVIA (sitagliptin) – a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. DPP-4 inhibitors, are believed to exert their actions in patients with type 2 diabetes by slowing the inactivation of incretin hormones. By increasing and prolonging active incretin levels, […]
SPIRIVA (tiotropium bromide) – an anticholinergic inhaled product commonly used to treat bronchospasm in patients with chronic obstructive pulmonary disease. FDA approved uses: Spiriva is indicated for the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), and for reducing COPD exacerbations. Available dosage forms: Capsules for oral inhalation. 18 mcg […]
OXYCONTIN (oxycodone) – an opioid agonist product commonly used to treat moderate to severe pain in patients requiring continuous around the clock opioid analgesia. FDA approved uses: Oxycontin is indicated for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. OxyContin is NOT […]